2.49 USD
-0.08 (-3.11%)
2.49 USD
0 (0%)
Overall OSUR gets a fundamental rating of 2 out of 10. We evaluated OSUR against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year OSUR has reported negative net income.
OSUR had a negative operating cash flow in the past year.
OSUR had negative earnings in 4 of the past 5 years.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
1.2 Ratios
OSUR has a Return On Assets (-14.24%) which is in line with its industry peers.
OSUR has a better Return On Equity (-16.64%) than 62.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROIC | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of OSUR (40.41%) is worse than 68.09% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
2. Health
2.1 Basic Checks
OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
OSUR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OSUR has more shares outstanding
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
2.2 Solvency
OSUR has an Altman-Z score of 1.78. This is a bad value and indicates that OSUR is not financially healthy and even has some risk of bankruptcy.
OSUR has a Altman-Z score of 1.78. This is comparable to the rest of the industry: OSUR outperforms 58.51% of its industry peers.
OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, OSUR is doing good in the industry, outperforming 75.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.78 |
ROIC/WACCN/A
WACC8.77%
2.3 Liquidity
OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Current ratio of 7.03 is amongst the best of the industry. OSUR outperforms 85.64% of its industry peers.
A Quick Ratio of 6.20 indicates that OSUR has no problem at all paying its short term obligations.
OSUR's Quick ratio of 6.20 is amongst the best of the industry. OSUR outperforms 86.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 |
3. Growth
3.1 Past
OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -633.33%.
OSUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.95%.
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
3.2 Future
The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.62% yearly.
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as OSUR's earnings are expected to decrease with -41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
5. Dividend
5.1 Amount
OSUR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.49
-0.08 (-3.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners90.77%
Inst Owner Change-1.49%
Ins Owners5.52%
Ins Owner Change2.1%
Market Cap178.61M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (84.34%)
Short Float %5.62%
Short Ratio6.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)-7.89%
EPS NQ rev (3m)-20.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.78%
Revenue NQ rev (1m)-15.19%
Revenue NQ rev (3m)-15.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.42 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.49 | ||
| P/tB | 0.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% | ||
| FCFM | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.29% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 | ||
| Altman-Z | 1.78 |
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OSUR.
Can you provide the valuation status for ORASURE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.
Can you provide the profitability details for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.
How financially healthy is ORASURE TECHNOLOGIES INC?
The financial health rating of ORASURE TECHNOLOGIES INC (OSUR) is 5 / 10.